SCHEMBL467449

SCHEMBL467449

[O]CCc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL315507 0.87 — —
SCHEMBL919385 0.86 — —
SCHEMBL922272 0.84 ALDH1A1 (0.56) —
SCHEMBL8146532 0.84 ALDH1A1 (0.54) —
SCHEMBL920064 0.82 ALDH1A1 (0.59) —
SCHEMBL921432 0.82 ALDH1A1 (0.59) —
SCHEMBL3989569 0.80 — —
SCHEMBL7094868 0.79 ALDH1A1 (0.67) —
SCHEMBL11060991 0.79 ALDH1A1 (0.61) —
SCHEMBL8906051 0.79 ALDH1A1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423742-B Benzotriazole-based compound, light absorber and resin composition 三井化学株式会社 2024-05-28 — — CN disclosed
CN-117466830-A Benzotriazole-based compound, light absorber and resin composition 三井化学株式会社 2024-01-30 — — CN disclosed
WO-2024005030-A1 DIPHENYLETHENE-BASED COMPOUND, LIGHT ABSORBER, RESIN COMPOSITION, AND USE THEREOF 山本化成株式会社 2024-01-04 — — WO disclosed
CN-116354931-A Substituted oxazole derivative and application thereof in medicines 广东东阳光药业有限公司 2023-06-30 — — CN disclosed
CN-114423742-A Benzotriazole compound, light absorber, and resin composition 三井化学株式会社 2022-04-29 — — CN disclosed
WO-2021054459-A1 BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION 三井化学株式会社 2021-03-25 — — WO disclosed
US-10308610-B2 Inhibitor compounds of phosphodiesterase type 10A AbbVie Deutschland GmbH & Co. KG (DE) 2019-06-04 — — US disclosed
US-20180099936-A1 NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A AbbVie Deutschland GmbH & Co. KG (DE) 2018-04-12 — — US disclosed
US-9856220-B2 Inhibitor compounds of phosphodiesterase type 10A AbbVie Deutschland GmbH & Co. KG (DE) 2018-01-02 — — US disclosed
EP-3169671-A1 SUBSTITUTED UREA DERIVATIVES AND PHARMACEUTICAL USES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2017-05-24 — — EP disclosed
EP-0232623-B1 1-CARBACEPHALOSPORIN ANTIBIOTICS ELI LILLY AND COMPANY (US) 1993-03-17 — — EP disclosed
US-5194662-A Insecticides, fungicides for plants BASF AKTIENGESELLSCHAFT (DE) 1993-03-16 — — US disclosed
EP-0487411-A1 Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments ROUSSEL UCLAF (FR) 1992-05-27 — — EP disclosed
EP-0463488-A1 O-Benzyl oxime ethers and fungicides containing them BASF Aktiengesellschaft (DE) 1992-01-02 — — EP disclosed
US-4892942-A 1-CARBA (DETHIA)CEPHALOSPORINS ELI LILLY AND COMPANY (US) 1990-01-09 — — US disclosed
US-4791106-A 1-Carbacephalosporin antibiotics ELI LILLY AND COMPANY (US) 1988-12-13 — — US disclosed
EP-0232623-A1 1-Carbacephalosporin antibiotics ELI LILLY AND COMPANY (US) 1987-08-19 — — EP disclosed
EP-0033255-B1 OXIMES DERIVED FROM ERYTHROMYCIN A, THEIR PREPARATION, THEIR APPLICATION IN PHARMACEUTICALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1984-08-29 — — EP disclosed
US-4349545-A Novel erythromycin a derivatives ROUSSEL UCLAF (FR) 1982-09-14 — — US disclosed
EP-0033255-A1 Oximes derived from erythromycin A, their preparation, their application in pharmaceuticals and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1981-08-05 — — EP disclosed
Send feedback